EB病毒性,epstein-barr
1)epstein-barrEB病毒性
1.Objective To explore clinical characteristics of epstein-barr(EB) virus encephalitis(EBE) in children.目的探讨小儿EB病毒性脑炎(EBE)的临床特点。
英文短句/例句

1.Clinical Study on pstein-Barr Virus Encephalitis儿童EB病毒性脑炎36例临床分析
2.The Clinical Research on Epstein-Barr Virus Associated Severe IM and HLH;EB病毒相关性重症IM和HLH的临床研究
3.Association of Epstein-Barr Virus and Rheumatoid ArthritisEB病毒与类风湿关节炎的相关性分析
4.Research advancement on relationship between Epstein-Barr virus and breast cancerEB病毒与乳腺癌的相关性研究进展
5.Determination of plasma EBV DNA in 91 children with EBV-associated diseases91例EB病毒相关疾病儿童血浆EB病毒DNA的检测
6.EB virus′ detections and analysis of related diseases that infected by EB virusEB病毒检测及EB病毒感染相关疾病的分析
7.Study on the Relationships between Epstein-Barr Virus Infection and Systemic Lupus Erythematosus;EB病毒感染与系统性红斑狼疮的相关性研究
8.Study on the Relationship between Epstein-Barr Virus and Systemic Lupus Erythematosus;EB病毒感染与系统性红斑狼疮相关性的研究
9.Study on the relationship between Epstein-Barr virus infection and systemic lupus erythematosusEB病毒感染与系统性红斑狼疮相关性研究
10.Latent Membrane Protein 1 Encoded by Epstein-Barr Virus Regulates p53 Function;EB病毒致瘤蛋白LMP1调节p53功能活性的研究
11.Analysis of Relationship Between Epstein-Barr Virus Infected in Children and Atypical Lymphocyte儿童EB病毒感染与异型淋巴细胞相关性的分析
12.The Correlation Between EB Virus Infection and Gastric Carcinoma and Gastric Lymphoma胃癌、胃淋巴瘤与EB病毒感染的相关性研究
13.The detection and significance of EB virus special antibodies in patients with lung cancer肺癌患者血清EB病毒特异性抗体检测及意义
14.Correlation of EB Virus Infection with Malignant Transformation of Host CellsEB病毒感染与宿主细胞恶性转化的关系
15.The Study of Relationships between EB Virus, HHV6 Infection and Systemic Lupus Erythematosus (SLE);EB病毒和人疱疹病毒6型感染与系统性红斑狼疮相关性的研究
16.Experimental Study on Targeted Viral Gene Therapy for Epstein-Barr Virus-Associated Tumor;特异性杀伤EB病毒相关肿瘤的病毒基因治疗的研究
17.Genotyping of Epstein-Barr Virus in Epstein-Barr Virus Associated Gastric CarcinomaEB病毒相关胃癌中病毒分型的研究
18.Progression of the Epstein-Barr virus-associated T-/NK cell lymphoproliferative diseasesEB病毒相关的T/NK细胞淋巴增殖性疾病的研究进展
相关短句/例句

EBV specificEB病毒特异性
3)EBVEB病毒
1.Study on relationship between EBV infection and ongene c-erbB-2 in breast carcinoma patients;乳腺癌患者EB病毒感染与癌基因c-erbB-2相关性的研究
2.Correlation of EBV infection and the expression of the c-erbB-2 gene in patients with gastric carcinoma;胃癌患者EB病毒感染与c-erbB-2基因表达的研究
3.TO STUDY THE RELATIONSHIP BETWEEN APOPTOSIS,EBV AND CLASSICAL HODGKIN LYMPHOMA BY USING TISSUE- CHIP;应用组织芯片探讨凋亡及EB病毒与经典型Hodgkin淋巴瘤的关系
4)EB virusEB病毒
1.Comparative study on the inhibition of EB virus antigen expression by common andrographis herb extract versus aciclovir;穿心莲提取物和阿昔洛韦对EB病毒抗原表达抑制作用的对比实验
2.The contrasting experiment to the inhibition of Redujing and Acyclovir on EB virus antigen expression;热毒净及阿昔洛韦对EB病毒抗原表达抑制作用的对比实验
3.Detection of EB virus ZEBRA/IgG antibody in nasopharyngeal carcinoma serum diagnosis;EB病毒ZEBRA/IgG抗体检测在鼻咽癌血清学诊断中的应用
5)epstein-barr virusEB病毒
1.Expression of heat shock protein-70 in systemic lupus erythematosus and its relationship with Epstein-Barr virus infection;HSP-70在SLE中的表达及其与EB病毒感染的相关性
2.Influence of Epstein-Barr virus latent membrane protein 2A on the proliferation of human gastric cancer cells;EB病毒潜伏期膜蛋白LMP2A对胃癌细胞增殖的影响
3.Influence of Epstein-Barr Virus on the differentiation and maturation of cord blood monocytes-derived dendritic cells;EB病毒对新生儿脐带血单核细胞来源的树突状细胞表型的影响
6)Epstein-Barr virus DNAEB病毒DNA
1.Detection of plasma free Epstein-Barr virus DNA of nasopharyngeal carcinoma with real time fluorescent quantitative polymerase chain reaction;实时荧光定量PCR法检测鼻咽癌患者血浆游离EB病毒DNA的临床应用
2.For the past few years,people have found that plasma cell-free Epstein-Barr virus DNA has important impact on diagnosis,staging,prognosis and monitoring therapeutic effect,which is better than the antibody detection.近年来,研究人员发现血浆游离EB病毒DNA对鼻咽癌的诊断、分期、疗效监测及判断预后方面都具有重要作用,并且优于目前较为普遍的抗体的检测,是新一代的有效检测指标。
3.Plasma Epstein-Barr virus DNA (EBV DNA) is a sensitive and specific molecular marker, which can reflect stage, response to treatment and prognosis of NPC.血浆EB病毒DNA(EBV DNA)浓度是一项能反映鼻咽癌分期、治疗反应、预后的灵敏、特异的分子生物学指标。
延伸阅读

[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]分子式:C16H16ClN3O3S分子量:365.5CAS号:26807-65-8性质:暂无制备方法:暂无用途:用于轻、中度原发性高血压。